Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KPI-121 in Postsurgical Inflammation
NCT02163824Phase 3Completed
- Sponsor
- KALA BIO
- Start
- May 2014
- Primary completion
- Dec 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of dexamethasone + loteprednol etabonate in post-operative ocular inflammation, sponsored by KALA BIO. Started May 2014; status: completed.
02
Drugs
dexamethasone + loteprednol etabonate
03
Conditions
post-operative ocular inflammation
Beyond the preview
Go deeper on NCT02163824.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02163824.